Disease/Infection News

RSS

ACTG announces the initiation of trial evaluating the safety and efficacy of monkeypox treatment

The AIDS Clinical Trials Group (ACTG), the largest global HIV research network, which expanded its focus to conduct research into COVID-19, today announced the initiation of STOMP (Study of Tecovirimat for Human Monkeypox Virus), or A5418, a phase 3, randomized, placebo-controlled, double-blind trial evaluating the safety and efficacy of tecovirimat for the treatment of human monkeypox.

9 Sep 2022

Novel antifungal medications urgently needed to control COVID-19-associated fungal infections

Every day we inhale thousands of potentially pathogenic fungal spores, but our immune system simply eliminates them.

9 Sep 2022

Weill Cornell Medicine receives $5 million NIH grant for next generation TB research

Weill Cornell Medicine has been awarded a five-year, $5 million grant from the National Institutes of Allergy and Infectious Diseases of the National Institutes of Health to establish a new multi-institutional center for tuberculosis (TB) research and training the next generation of TB investigators.

9 Sep 2022

New antiviral treatment may limit the transmission of SARS-CoV-2 virus

By the time you test positive for COVID-19, the SARS-CoV-2 virus has already taken up residence in your respiratory system. With each breath, you expel invisible viral particles into the air - a process known as viral shedding.

9 Sep 2022

New research project investigates molecular mechanisms underlying NeuroCOVID

Infections with the coronavirus SARS-CoV-2 can trigger both temporary and long-term neurological and neuropsychiatric symptoms, severely impacting patients and the wider society.

9 Sep 2022

Duke researchers identify chlamydia’s stealthy cloaking device

Chlamydia, the leading cause of sexually transmitted bacterial infections, evades detection and elimination inside human cells by use of a cloaking device. But Duke University researchers have grasped the hem of that invisibility cloak and now hope they can pull it apart.

9 Sep 2022

Phase 3 clinical trial commences to evaluate antiviral for monkeypox

A Phase 3 clinical trial evaluating the antiviral tecovirimat, also known as TPOXX, is now enrolling adults and children with monkeypox infection in the United States.

9 Sep 2022

Pakistan faces widespread outbreaks of infectious diseases amid unprecedented floods

Amid unprecedented floods which have affected 33 million people and damaged nearly 900 health facilities, Pakistan faces the risk of widespread outbreaks of diseases, including diarrhoea, dengue, malaria, polio and COVID-19.

9 Sep 2022

Potential HIV vaccine component leads to strong protection in primates

To block infection from HIV, a successful vaccine will require a combination of ingredients, including at least three antibody targets and a substance that boosts immune responses.

9 Sep 2022

Monkeypox can sometimes lead to encephalitis, confusion or seizures

Monkeypox can sometimes lead to neurological complications such as encephalitis (brain inflammation), confusion or seizures, finds a new review of evidence led by a UCL researcher.

9 Sep 2022

Study finds wide geographic variance in behavioral and social drivers of COVID-19 vaccination

In the first year of its availability, 84.2% of US adults received at least one dose of COVID-19 vaccine. Progress in COVID-19 vaccination slowed after April 2021, and millions of Americans remain unvaccinated.

9 Sep 2022

Individual COVID-19 infections include multiple variants of the SARS-CoV-2 virus, research shows

Researchers at Case Western Reserve University found wide genetic variation in SARS-CoV-2 viruses among 360 patients whose viral infections were genetically sequenced, showing that all individual infections include multiple variants of the virus.

9 Sep 2022

Can cod liver oil supplementation prevent COVID-19 and other acute respiratory infections?

A new study aimed to analyze whether cod liver oil could prevent serious COVID-19, SARS-CoV-2 infection, or other acute respiratory infections during the winter of 2020-2021.

9 Sep 2022

Respirator masks used by anesthetists associated with 38% increased risk of airway complications in patients

Personal protective equipment (PPE) was rarely out of the news throughout the peaks of the COVID-19 pandemic.

9 Sep 2022

Factors influencing patient’s perception during COVID-19 recovery

A team of researchers characterized individual-level illness perception, both cognitive and emotional, following COVID-19.

9 Sep 2022

COVID-19’s long-term impact on orphanhood and caregiver loss

Researchers performed epidemiologic modeling to update COVID-19-associated caregiver and parent loss estimates.

9 Sep 2022

The evolution of humoral immune responses over the course of Epstein-Barr virus infection

Researchers explored probable humoral immune mechanisms related to EBV curtailment, besides neutralization, by a systematic emphasis on antibody fragment crystallizable-functional activities over the course of EBV infections.

9 Sep 2022

All SARS-CoV-2 variants neutralized by a potent new antibody

Researchers describe a mouse model used to generate a VH1-2 heavy chain (HC)- and Vκ1-33 light chain (LC)-based recombinant antibody that broadly neutralized all severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants, including the newly emergent Omicron sub-variant BA.5.

9 Sep 2022

Supplementary folic acid associated with higher risk of COVID-19 diagnosis and mortality

In a recent study published in the journal BMJ Open, researchers investigated the impact of folic acid supplements and methotrexate, in combination or individually, on disease severity and mortality in coronavirus disease 2019 (COVID-19) cases.

8 Sep 2022

Significantly enlarged gray matter volume in neuropsychiatric long-COVID syndrome

In a recent study published in the journal Psychiatry Research, researchers found larger gray matter volumes (GMVs) in patients with neuropsychiatric long COVID syndrome.

8 Sep 2022

Disease/Infection News

ACTG announces the initiation of trial evaluating the safety and efficacy of monkeypox treatment

Novel antifungal medications urgently needed to control COVID-19-associated fungal infections

Weill Cornell Medicine receives $5 million NIH grant for next generation TB research

New antiviral treatment may limit the transmission of SARS-CoV-2 virus

New research project investigates molecular mechanisms underlying NeuroCOVID

Duke researchers identify chlamydia’s stealthy cloaking device

Phase 3 clinical trial commences to evaluate antiviral for monkeypox

Pakistan faces widespread outbreaks of infectious diseases amid unprecedented floods

Potential HIV vaccine component leads to strong protection in primates

Monkeypox can sometimes lead to encephalitis, confusion or seizures

Study finds wide geographic variance in behavioral and social drivers of COVID-19 vaccination

Individual COVID-19 infections include multiple variants of the SARS-CoV-2 virus, research shows

Can cod liver oil supplementation prevent COVID-19 and other acute respiratory infections?

Respirator masks used by anesthetists associated with 38% increased risk of airway complications in patients

Factors influencing patient’s perception during COVID-19 recovery

COVID-19’s long-term impact on orphanhood and caregiver loss

The evolution of humoral immune responses over the course of Epstein-Barr virus infection

All SARS-CoV-2 variants neutralized by a potent new antibody

Supplementary folic acid associated with higher risk of COVID-19 diagnosis and mortality

Significantly enlarged gray matter volume in neuropsychiatric long-COVID syndrome

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Latest News